Lifestyle

Discrimination Associated With Higher Risk of Depression

A group of researchers explored whether individuals who experienced ongoing discrimination had a higher risk for depression.

Do Concussions Contribute to Mental Health Disorders in Youths?

David Howell, PhD; and Heather Sesma, PhD; provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.

Anxiety in Children and Adults Ballooned in US at Start of COVID-19 Pandemic

The authors discuss identifying and treating anxiety disorders in children and adults in primary care during COVID-19.

FDA Cracks Down on Honey-Based Products Tainted With Undeclared Drugs

The products were being promoted and sold for sexual enhancement on various websites and online marketplaces, and possibly in some retail stores.

Change of National Suicide Prevention Lifeline Number to 988

The National Suicide Prevention Lifeline (1-800-275-TALK (8255)) will change to 988 as of July 16, 2022.

AAD Releases Guideline to Increase Awareness on Comorbidities in Atopic Dermatitis

A new American Academy of Dermatology (AAD) guideline describes available evidence on comorbidities associated with atopic dermatitis (AD) in adults.

COVID-19 and Alcohol: A Pandemic Collides With a Public Health Crisis

Amid the global COVID-19 pandemic that overwhelmed hospitals, upended the economy, and sent much of the world into lockdown, researchers tracked a concerning uptick in alcohol use.

Lower Ventral Striatum Activity Associated With Depression in Teens

Researchers used data from a European sample of teens from the IMAGEN Consortium study, which measured resting-state fMRI activity at age 14, 16, and 18.

Adolescent Boys With Autism Spectrum Disorder at a Nearly 3-Fold Higher Risk for Self-Harm

Investigators at King’s College London in the UK evaluated data from a national database of adolescents aged who were enrolled in 4 state-maintained school and resident programs from their 11th birthday or April 2009 to presentation at an emergency department for self-harm, their 18th birthday, or March 2013.

Depression Increases Mortality Risk in Incident Rheumatoid Arthritis

Researchers investigated the mortality risk associated with depression in patients with incident rheumatoid arthritis.

TMS for Multiple Sclerosis: Can It Help Treat Depressive Symptoms?

In a quantitative study, researchers assessed the efficacy of TMS on depressive symptoms in people with MS.

Trial Evaluating Zuranolone for Postpartum Depression Meets All Endpoints

Zuranolone is an investigational oral neuroactive steroid GABA-A receptor positive allosteric modulator.

Cannabis May Ease Depression and Anxiety Long-Term

Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.

Wuling Capsule for Insomnia in Adults: How Safe and Effective Is It?

In a retrospective, systematic review, researchers assessed the effectiveness and safety profile of Wuling for the treatment of insomnia.

Anxiety and Depression: Understanding the Risk for Preeclampsia

Rates of anxiety and depression have increased during the pandemic and are linked to preeclampsia risk, making screening for mental health conditions at prenatal visits essential.

Integrated Cognitive and Balance Intervention Improves Depression Symptoms

The ENGAGE-2 Mechanistic Pilot trial was a randomized clinical trial conducted at the University of Illinois at Chicago and Stanford University between 2019 and 2020.

Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments

The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.

Resilience Mediates Anxiety, Depression in Youth Who Experience Bullying

This study was a cross-sectional analysis of data from the Youth Aware of Mental Health promotion program which took place in Texas.

Social Determinants Affect Treatment Response in Those With Major Depression

The researchers evaluated socioeconomic data from the 2011 Combining Medications to Enhance Depression Outcomes (CO-MED) study to ascertain whether social determinants affect treatment response in those with major depression.

Neonatal Exposure to Antipsychotics Does Not Substantially Increase Risk for Neurodevelopmental Disorders

Investigators with Brigham and Women’s Hospital sourced data for this study from the Medicaid Analytic eXtract (MAX) and IBM Health MarketScan Research Database.